Inhibition of Histone Deacetylases 1 and 6 Enhances Cytarabine-Induced Apoptosis in Pediatric Acute Myeloid Leukemia Cells
2011

Enhancing Chemotherapy in Pediatric AML with HDAC Inhibitors

Sample size: 4 publication 10 minutes Evidence: high

Author Information

Author(s): Xu Xuelian, Xie Chengzhi, Edwards Holly, Zhou Hui, Buck Steven A., Ge Yubin

Primary Institution: Wayne State University School of Medicine

Hypothesis

Which members of the HDAC family are involved in cytarabine sensitivities in pediatric acute myeloid leukemia (AML)?

Conclusion

Inhibition of HDACs 1 and 6 enhances cytarabine-induced apoptosis in pediatric AML cells.

Supporting Evidence

  • Down-regulation of HDACs 1 and 6 significantly increased cytarabine-induced apoptosis.
  • HDAC inhibitors showed varying levels of effectiveness in enhancing apoptosis in pediatric AML cells.
  • Simultaneous inhibition of HDACs 1 and 6 resulted in the best anti-leukemic activities.

Takeaway

This study found that blocking certain proteins can help make leukemia cells more sensitive to a common chemotherapy drug, which could help kids with leukemia get better treatment.

Methodology

The study used Western blotting, flow cytometry, and shRNA knockdown to analyze the effects of HDAC inhibitors on pediatric AML cell lines.

Potential Biases

Potential bias in selecting cell lines and interpreting results based on specific HDAC inhibitors.

Limitations

The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.

Participant Demographics

Pediatric patients with acute myeloid leukemia.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017138

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication